Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease
2019
ObjectivesThe aim of this open-label study was to investigate the long-term safety and efficacy of selegiline as monotherapy in Japanese patients with early Parkinson disease (PD).MethodsWe conducted a 56-week prospective study in patients with early PD (N = 134) who had previously completed the ran
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
18
References
0
Citations
NaN
KQI